NKGN NKGen Biotech Company Profit

Anticipation of the clinical trial results for Alzheimer's disease therapy will serve as a key trigger for NKGen Biotech, Inc. (NKGN). The company's net income illustrates the financial dynamics during a period of tight Fed policy, where 0.00 shows the level of this metric. Growth relies on partnerships with medical centers for NK-cell research and the implementation of AI bioreactors to reduce costs when scaling cellular products.

NKGen (NKGN) Net Profit: for the period 02/21/2024 - 03/15/2025

Analytical breakdowns and data insights for company NKGen Biotech (NKGN)

- stock value and consensus price forecast:
Market Price NKGen Biotech Corp|NKGN - Price Target Chart
- market capitalization data:
Market Capitalization NKGen Biotech Corp|NKGN - Total Company Value
- book capitalization information:
Book Value per Share NKGen Biotech|NKGN - Book Capitalization|Market Value to Equity Ratio nkgenbiotech.com|NKGN - Company Total Assets
- debt and liquidity details:
Debt to Capital NKGen Biotech, Inc.|NKGN - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio NKGen Biotech Inc|NKGN - Company Total Debt|Debt to Net Assets Ratio NKGen Biotech Corp|NKGN - Company Long-Term Debts|Company Short-Term Debt NKGen Biotech|Interim Coverage Ratio nkgenbiotech.com
- earnings and market multiples details:
NKGN - Company Net Income
Summary company analysis:NKGen Biotech Corp (NKGN)

To select fundamentally resilient assets, it is critical for investors to evaluate a business's ability to generate real commercial value. This metric aggregates daily net income trends, allowing the company's financial results to filter out market noise and reveal the efficiency of capital management amid the fierce competition faced by NKGen Biotech (NKGN) in the pre-revenue cell therapy segment for neurodegenerative diseases.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|Company Profit RGC (regencellbioscience.com)|Company Net Income Axsome Therapeutics, Inc. (AXSM)|Net Profit ACADIA Pharma (ACAD)|Net Profit XENE (Xenon Pharmaceuticals Inc)|Annual Net Income Viking Therapeutics Corp|Supernus Pharmaceuticals - Net Profit|Company Net Income catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Company Net Income|Company Profit HRMY|Net Income BHVN|AMLX: Final Profit|Net Profit TRVI|Company Net Income PRAX (praxismedicines.com)|Net Profit AVXL (Anavex Life Sciences Corp.)|Net Financial Result CeriBell Inc (CBLL)|PRTA - Company Net Income|Company Net Income Alector, Inc.|ANNX (Annexon, Inc.) - Net Income|OMER: Profit After Payment of Taxes|NGNE (Neurogene) - Net Profit|Company Net Income AC Immune S.A. ACIU|Net Profit VYGR|Net Income Neumora Corp NMRA|Net Profit SCLX (Scilex Holding Company)|Final Profit TVGN|ACOG: Net Income|Final Profit CGTX (cogrx.com)|IKT: Net Profit|SAVA - Net Financial Result|Company Net Income Assertio Holdings|Company Profit COYA (Coya)|Net Profit VTGN|Net Income ovidrx.com OVID|Acumen Pharma - Net Income|Net Financial Result CervoMed Corporation (CRVO)|ATHE - Company Net Income|CLNN (Clene Inc.) - Company Profit|pepgen.com (PEPG) - Company Net Income|jupiterneurosciences.com (JUNS) - Net Profit|RLMD (Relmada) - Net Profit|ANVS - Annual Net Income|Company Net Income Grace Therapeutics, Inc. (GRCE)|fireflyneuro.com - Company Profit|Company Net Income Klotho Neurosciences KLTO|NRSN: Company Profit|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|NRXS (NeurAxis, Inc.) - Net Income|Helius Medical Technologies (HSDT) - Net Profit|Company Net Income Passage Bio Inc.|NEUP: Final Profit|Company Net Income Minerva Neurosciences Corp (NERV)|ATHA - Company Net Income|Company Net Income Addex Therapeutics ADXN|ALZN: Company Profit|CYCN - Company Net Income|PTIX - Net Profit|KTTA: Net Profit|Annual Net Income Cortigent CRGT|ATXI (Avenue Therapeutics) - Net Profit|Company Net Income brainstorm-cell.com BCLI|Company Net Income Cara Therapeutics (CARA)|Chromocell Therapeutics Corp - Company Profit|Eliem Therapeutics Inc. - Net Income|Final Profit ITCI|Longboard Pharmaceuticals - Net Profit|MRNS: Company Net Income|NRBO: Net Profit|SAGE - Net Financial Result|Company Net Income Neurotrope|Company Net Income Trevena Inc TRVN|Net Income VIGL (Vigil Neuroscience)|Profit After Payment of Taxes WENA|Net Profit CERE (Cerevel Therapeutics, Inc.)